Effects of corneal thickness on the intraocular penetration of travoprost 0.004%.

Eye
J M Martinez-de-la-CasaJ Garcia-Sanchez

Abstract

To determine whether the intraocular penetration of travoprost 0.004% is affected by central corneal thickness. Sixty-four patients who were scheduled for cataract surgery without any other ophthalmologic pathology of significance were enrolled in this study. At 120 min before surgery, one drop of travoprost 0.004% was instilled in the eye to be operated on. At the start of surgery, a sample of aqueous humour was extracted to subsequently determine its AL-5848 concentration. These concentrations were compared among three groups of patients established according to central corneal thickness measurements obtained by ultrasound pachymetry. Mean AL-5848 concentrations were 3.27±2.03 ng/ml in Group I (CCT<511 microns), 3.27±2.44 ng/ml in Group II (CCT≥511 and ≤574 microns), and 2.73±2.15 ng/ml in Group III (CCT>574 microns), indicating no significant differences among the groups. We were unable to demonstrate the greater or lesser penetration of travoprost depending on corneal thickness, which could explain differences in patient responses to this drug.

References

Aug 1, 1983·American Journal of Epidemiology·M C Leske
Oct 9, 2002·Archives of Ophthalmology·Anders HeijlUNKNOWN Early Manifest Glaucoma Trial Group
Jan 14, 2003·Archives of Ophthalmology·M Cristina LeskeUNKNOWN Early Manifest Glaucoma Trial Group
Nov 9, 2004·American Journal of Ophthalmology·James D BrandtUNKNOWN Ocular Hypertension Treatment Study (OHTS) Group
Jan 2, 2007·Cornea·Paul J HarasymowyczUNKNOWN Travoprost Central Corneal Thickness Study Group
May 23, 2007·Archivos de la Sociedad Española de Oftalmología·H Sánchez-TocinoD Iglesias-Cortiñas
Oct 19, 2007·The Cochrane Database of Systematic Reviews·C VassL Schmetterer
Mar 18, 2008·Journal of Glaucoma·Thomas V JohnsonCarl B Camras
Feb 24, 2009·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Marcelo HatanakaRemo Susanna
Oct 28, 2009·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Torsten SchloteMyron Kynigopoulos

❮ Previous
Next ❯

Citations

Aug 11, 2015·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Oriel SpiererYossi Yatziv
Mar 26, 2015·PloS One·Deepak P EdwardKhaled K Abu Amero
Feb 16, 2018·Eye·Graham W Belovay, Ivan Goldberg
Oct 21, 2016·Current Opinion in Ophthalmology·Chelvin C A SngKeith Barton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Clinical & Experimental Ophthalmology
P R Healey
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
Hyung Jun Kim, Byung Joo Cho
© 2021 Meta ULC. All rights reserved